Advertisement
Research Article

Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways

  • Christian Grant,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Unsong Oh,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Kazunori Fugo,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Norihiro Takenouchi,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Caitlin Griffith,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Karen Yao,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Timothy E Newhook,

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Lee Ratner,

    Affiliation: Departments of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Steven Jacobson mail

    To whom correspondence should be addressed. E-mail: jacobsons@ninds.nih.gov

    Affiliation: Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: April 28, 2006
  • DOI: 10.1371/journal.ppat.0020033

Reader Comments (0)

Post a new comment on this article